[{"Assets_0_Q2_USD":10858035000.0,"CommonStockSharesOutstanding_0_Q2_shares":223929771.0,"EarningsPerShareBasic_1_Q2_USD":-0.27,"EarningsPerShareBasic_2_Q2_USD":-2.53,"EarningsPerShareDiluted_1_Q2_USD":-0.27,"EarningsPerShareDiluted_2_Q2_USD":-2.53,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":219132000.0,"NetIncomeLoss_1_Q2_USD":-60867000.0,"NetIncomeLoss_2_Q2_USD":-566356000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":223834000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":223677000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":223834000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":223677000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]